3 Growth Stocks to Add to Your Roster

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.

The risks that can come from buying these assets is precisely why we started StockStory – to isolate the long-term winners from the losers so you can invest with confidence. On that note, here are three growth stocks with significant upside potential.

One-Year Revenue Growth: +26.7%

With its colorful interface of boards, columns, and automation that replaced the chaos of spreadsheets, monday.com (NASDAQ:MNDY) is a cloud-based work operating system that helps teams manage projects, track tasks, and streamline workflows through customizable interfaces.

Why Is MNDY a Good Business?

1. ARR growth averaged 26.9% over the last year, showing customers are willing to take multi-year bets on its software

2. Superior software functionality and low servicing costs are reflected in its best-in-class gross margin of 89.2%

3. Software platform has product-market fit given the rapid recovery of its customer acquisition costs

monday.com’s stock price of $62.45 implies a valuation ratio of 2.4x forward price-to-sales. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.

One-Year Revenue Growth: +25.2%

One of two remaining major hard drive manufacturers after decades of industry consolidation, Seagate (NASDAQ:STX) manufactures hard disk drives and solid state drives that store data in data centers, cloud systems, and consumer devices.

Why Are We Fans of STX?

1. Impressive 24.7% annual revenue growth over the last two years indicates it’s winning market share this cycle

2. Estimated revenue growth of 28.7% for the next 12 months implies demand will accelerate from its two-year trend

3. Operating margin increased by 8 percentage points over the last five years as it refined its cost structure

At $501.95 per share, Seagate trades at 29.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

One-Year Revenue Growth: +56.4%

Formerly known as Apollo Medical Holdings until early 2024, Astrana Health (NASDAQ:ASTH) operates a technology-powered healthcare platform that enables physicians to deliver coordinated care while successfully participating in value-based payment models.

Why Does ASTH Stand Out?

1. Annual revenue growth of 51.5% over the last two years was superb and indicates its market share increased during this cycle

2. Revenue outlook for the upcoming 12 months is outstanding and shows it’s on track to gain market share

3. Earnings per share grew by 15.9% annually over the last five years and trumped its peers

Astrana Health is trading at $28.23 per share, or 10.2x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.